Novacyt Sa Stock Analysis

Novacyt Pink Sheet Analysis Notes

The company has price-to-book ratio of 0.4. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Novacyt SA recorded a loss per share of 0.17. The entity had not issued any dividends in recent years. The firm had 15:1 split on the 28th of June 2012. Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Vlizy-Villacoublay, France. Novacyt operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 210 people.The quote for Novacyt SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Novacyt SA contact the company at 33 1 39 46 51 04 or learn more at https://www.novacyt.com.

Novacyt SA Investment Alerts

Novacyt Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 83.34 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novacyt SA's market, we take the total number of its shares issued and multiply it by Novacyt SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Novacyt Profitablity

The company has Profit Margin (PM) of (0.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

Technical Drivers

As of the 20th of December, Novacyt SA secures the Standard Deviation of 4.56, risk adjusted performance of (0.08), and Mean Deviation of 1.63. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novacyt SA, as well as the relationship between them. Please verify Novacyt SA market risk adjusted performance, total risk alpha, as well as the relationship between the Total Risk Alpha and kurtosis to decide if Novacyt SA is priced some-what accurately, providing market reflects its recent price of 0.64 per share. As Novacyt SA is a penny stock we also strongly advise to check its jensen alpha numbers.

Novacyt SA Price Movement Analysis

Novacyt SA Predictive Daily Indicators

Novacyt SA Forecast Models

Novacyt SA's time-series forecasting models are one of many Novacyt SA's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novacyt SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Novacyt SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novacyt shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Novacyt SA. By using and applying Novacyt Pink Sheet analysis, traders can create a robust methodology for identifying Novacyt entry and exit points for their positions.

When running Novacyt SA's price analysis, check to measure Novacyt SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novacyt SA is operating at the current time. Most of Novacyt SA's value examination focuses on studying past and present price action to predict the probability of Novacyt SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novacyt SA's price. Additionally, you may evaluate how the addition of Novacyt SA to your portfolios can decrease your overall portfolio volatility.